0001209191-21-055448.txt : 20210910
0001209191-21-055448.hdr.sgml : 20210910
20210910162311
ACCESSION NUMBER: 0001209191-21-055448
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210908
FILED AS OF DATE: 20210910
DATE AS OF CHANGE: 20210910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blaustein Marc
CENTRAL INDEX KEY: 0001880032
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40227
FILM NUMBER: 211247312
MAIL ADDRESS:
STREET 1: C/O FINCH THERAPEUTICS GROUP, INC.
STREET 2: 200 INNER BELT ROAD, SUITE 400
CITY: SOMERVILLE
STATE: MA
ZIP: 02143
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Finch Therapeutics Group, Inc.
CENTRAL INDEX KEY: 0001733257
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823433558
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 INNER BELT ROAD
CITY: SOMERVILLE
STATE: MA
ZIP: 02143
BUSINESS PHONE: 617-229-6499
MAIL ADDRESS:
STREET 1: 200 INNER BELT ROAD
CITY: SOMERVILLE
STATE: MA
ZIP: 02143
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-09-08
1
0001733257
Finch Therapeutics Group, Inc.
FNCH
0001880032
Blaustein Marc
C/O FINCH THERAPEUTICS GROUP, INC.
200 INNER BELT ROAD, SUITE 400
SOMERVILLE
MA
02143
0
1
0
0
Chief Operating Officer
No securities beneficially owned.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Sydney Gaylin, Attorney-in-Fact
2021-09-10
EX-24.3_1007812
2
poa.txt
POA DOCUMENT
Exhibit 24
POWER OF ATTORNEY
Know all by these present, that the undersigned hereby constitutes and appoints
each of Joseph Vittiglio and Sydney Gaylin of Finch Therapeutics Group, Inc.,
and Divakar Gupta, Courtney T. Thorne, Trey Reilly and Jason Minio of Cooley
LLP, with full power of substitution, signing individually, the undersigned's
true and lawful attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director or beneficial owner of more than 10% of a registered
class of securities of Finch Therapeutics Group, Inc., Forms 3, 4, and 5
(including any amendments thereto), relating to the securities of Finch
Therapeutics Group, Inc., in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder
and a Form ID, Uniform Application for Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to execute such Forms 3, 4, or 5, or Form ID
(including any amendments thereto) and timely file such forms with the United
States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is Finch Therapeutics Group, Inc. assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by Finch Therapeutics Group, Inc., (b) revocation by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact is no longer employed
by Finch Therapeutics Group, Inc. or Cooley LLP.
The undersigned has caused this Power of Attorney to be executed as of August
16, 2021.
/s/ Marc Blaustein
Marc Blaustein